Evaluating DFPP for microplastic reduction
Part of Blood & lymphatic clinical trials.
This trial tests whether DFPP, a blood filtration treatment you may already be receiving, can reduce microplastics in your blood. If you are already scheduled for DFPP, you may help us learn more about its benefits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You weigh more than 88 pounds (40 kg)
- Your doctor has already prescribed DFPP (a blood filtering treatment) for you
- You have not had another blood filtering treatment (plasmapheresis) in the past 7 days
- You are willing to give blood samples before and after your DFPP session
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new plasma filter, PX2, used in a procedure called therapeutic plasma exchange (TPE) to clean harmful substances from your blood. It’s for people who already need TPE and can safely use a blood thinner during the treatment.
This study compares two ways of filtering your blood (plasmapheresis) to see how each affects your blood's ability to clot. If you already receive regular plasmapheresis with citrate, you might help doctors learn which method is safer for you.
This trial tests a dried (lyophilized) form of blood plasma that can be mixed with water and given to patients who need plasma transfusions. The goal is to see if this dried plasma is safe and works as well as frozen plasma for treating bleeding or reversing the effects of blood thinners like warfarin.
This study tests a treatment made from your own blood (platelet-rich plasma) to help heal chronic diabetic foot ulcers. It aims to see if this treatment can improve wound healing compared to standard care.
This study looks at how microplastics might affect fertility in men and women. It involves collecting samples like blood, stool, and reproductive fluids to see if there's a link.
This trial tests a treatment that reduces certain antibodies in your blood, which may help slow the progression of IPF. The treatment involves a procedure to filter your blood and then giving you antibodies to help your immune system.
Hear when a new Microplastic and Nanoplastic Particle Burden in Peripheral Blood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.